TRON Seminar in Translational Oncology: Dr. Matthew L. Albert

November 22, 2012

5 PM in Mainz, Germany

TRON – Building 708 at University Medical Center Mainz

Langenbeckstr. 1

55131 Mainz

Dr. Matthew L. Albert

Director of Research INSERM and Head of the Laboratory of Dendritic Cell Immunobiology at the Institut Pasteur, Paris


“Making biomarkers functional – a path towards personalized medicine”

Dr. Matthew L. Albert Director of Research INSERM and Head of the Laboratory of Dendritic Cell Immunobiology at the Institut Pasteur, Paris, leading a team in the area of dendritic cell immunobiology and tumor immunity.

His research focuses on:

  • Apoptosis and cross-presentation
  • The role of autophagy for Ag-delivery to DCs for efficient CD8+ T cell priming
  • Signalling networks that regulate antigen cross-presentation
  • The role of CD4+ T cell help in in cross-presentation
  • Establishment of two new human models for the study of cross-presentation
  • Chemokine antagonism in chronic HCV patients
  • Generation of a 1st generation map of the inflammatory response to intravesical BCG
  • Mechanisms of tumor immunity in patients with superficial transitional cell carcinoma of the bladder
  • Combinatorial tetramer staining, magnetic-bead enrichment, and multiparametric cytometry for the detection of Ag-specific T Cells


More information on Matthew L. Albert